STONY BROOK, NY / ACCESSWIRE / / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the completion of the buildout of ...
(NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies ... that clients can utilize for the production of mRNA clinical trial materials. The facility is undergoing ...
Gen-Probe is currently developing the APTIMA HPV Assay, targeting E6/E7 mRNA from 14 carcinogenic HPV genotypes. A prototype of this assay was evaluated recently in 536 women with histological ...
Using the polymerase chain reaction ("PCR") to enable both the production ... RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; (ii) the detection of DNA and RNA in molecular ...